Teachers Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $9.31M | Sell |
134,190
-50,326
| -27% | -$3.49M | 0.01% | 1032 |
|
|
2018
Q4 | $8.02M | Buy |
184,516
+2,606
| +1% | +$113K | 0.01% | 1047 |
|
|
2018
Q3 | $13.9M | Sell |
181,910
-83,878
| -32% | -$6.4M | 0.02% | 911 |
|
|
2018
Q2 | $20.4M | Buy |
265,788
+9,237
| +4% | +$710K | 0.03% | 723 |
|
|
2018
Q1 | $13.1M | Buy |
256,551
+67,276
| +36% | +$3.43M | 0.02% | 920 |
|
|
2017
Q4 | $8.78M | Buy |
189,275
+19,458
| +11% | +$903K | 0.01% | 1096 |
|
|
2017
Q3 | $9.04M | Sell |
169,817
-69
| -0% | -$3.68K | 0.01% | 1069 |
|
|
2017
Q2 | $10.6M | Buy |
169,886
+5,988
| +4% | +$372K | 0.01% | 975 |
|
|
2017
Q1 | $11.1M | Buy |
163,898
+5,203
| +3% | +$353K | 0.02% | 940 |
|
|
2016
Q4 | $11.2M | Sell |
158,695
-14,570
| -8% | -$1.02M | 0.02% | 907 |
|
|
2016
Q3 | $12.3M | Buy |
173,265
+510
| +0.3% | +$36.2K | 0.02% | 846 |
|
|
2016
Q2 | $8.45M | Buy |
172,755
+8,308
| +5% | +$406K | 0.01% | 948 |
|
|
2016
Q1 | $10.4M | Buy |
164,447
+28,249
| +21% | +$1.79M | 0.02% | 843 |
|
|
2015
Q4 | $15.3M | Buy |
136,198
+30,866
| +29% | +$3.46M | 0.03% | 639 |
|
|
2015
Q3 | $10.1M | Buy |
105,332
+52,856
| +101% | +$5.09M | 0.02% | 845 |
|
|
2015
Q2 | $5.37M | Buy |
52,476
+42,169
| +409% | +$4.32M | 0.01% | 1144 |
|
|
2015
Q1 | $640K | Buy |
10,307
+927
| +10% | +$57.6K | ﹤0.01% | 2291 |
|
|
2014
Q4 | $412K | Hold |
9,380
| – | – | ﹤0.01% | 2543 |
|
|
2014
Q3 | $531K | Hold |
9,380
| – | – | ﹤0.01% | 2367 |
|
|
2014
Q2 | $421K | Sell |
9,380
-300
| -3% | -$13.5K | ﹤0.01% | 2526 |
|
|
2014
Q1 | $473K | Buy |
+9,680
| New | +$473K | ﹤0.01% | 2436 |
|